CN101750457B - Method for measuring ciclopirox olamine - Google Patents
Method for measuring ciclopirox olamine Download PDFInfo
- Publication number
- CN101750457B CN101750457B CN200910117707XA CN200910117707A CN101750457B CN 101750457 B CN101750457 B CN 101750457B CN 200910117707X A CN200910117707X A CN 200910117707XA CN 200910117707 A CN200910117707 A CN 200910117707A CN 101750457 B CN101750457 B CN 101750457B
- Authority
- CN
- China
- Prior art keywords
- ciclopirox olamine
- solution
- sample
- acetonitrile
- ciclopirox
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a method for measuring ciclopirox olamine. A chromatographic column with C18 hydrophilic filler is selected, the clathration of beta-cyclodextrin on ciclopirox olamine is utilized, blended solution of aqueous solution of beta-cyclodextrin and acetonitrile is used as a mobile phase, an ultraviolet detector is adopted, and the method can be used for quantitatively measuring active ingredient ciclopirox olamine in a ciclopirox olamine emulsifiable paste. The method has low detection limit and wide linear range; and the linear range well covers the medicament concentration range of the ciclopirox olamine, so that the method can be well used for fast detection of the ciclopirox olamine in the medicament production process and clinical medicament monitoring.
Description
Technical field
The invention belongs to the analytical chemistry field, relate to a kind of method of measuring Ciclopirox Olamine, a kind of efficient liquid-phase chromatography method of measuring Ciclopirox Olamine in the Ciclopirox Olamine emulsifiable paste through cyclodextrin encapsulated Ciclopirox Olamine of saying so more specifically.
Background technology
Ciclopirox Olamine has another name called ciclopirox olamine, cyclopirox amine.Molecular formula is C
14H
24N
2O
3, its structural formula is following:
Molecular weight is 268.36, has the characteristics of the serum infiltration of hypotoxicity and brute force, and it has powerful sterilization functions to dermatophyte, Candida albicans etc., on the fungus-caused skin keratin disease of treatment, effect is preferably arranged.Its concentration can suppress dermatophyte and saccharomycete when being 4~8 μ g/ml; Also there is inhibiting effect (to draw 28-NF23, United States Pharmacopoeia Convention, Inc. to Escherichia coli, proteus, staphylococcus aureus, hemolytic streptococcus etc. during higher concentration (16~78 μ g/ml) from document 1:United States Pharmacopoeia; Rockville; MD, 2005, p.470.).Hence one can see that, and the concentration of Ciclopirox Olamine is very important for the superficial fungi and the candida albicans infection that suppress epidermis or mucous membrane.The method of detection by quantitative chain rate ketoamine concentration has following several kinds at present:
Though being the most frequently used detection technique, the spectrophotometry Ciclopirox Olamine (draws from document 2: Ai Yusuo the spectrophotometry of Ciclopirox Olamine emulsifiable paste content; Northwest pharmaceutical journal .19905 (1) 2~3), but since its accurate quantification and in similar compound the deficiency of specific assay Ciclopirox Olamine, this method can not be applied to the quality control in stability study and the medicine production process.Other has document (to draw from document 3:Escarrone; A.L.V.et al LC-UV method with pre-columnderivatization for the determination of ciclopirox olamine in raw material andtopical solution Chromatographia 200867 (11-12) 967-971) introduces; Use the way detection by quantitative Ciclopirox Olamine of deriving before the performance liquid chromatographic column; Must be through complicated column front derivation step; But the derivatization process makes other component unstable, and is not suitable for the fast detecting in the medicine production process.
American Pharmacopeia (USP) has a kind of method with high performance liquid chromatography detection Ciclopirox Olamine (to draw the 28-NF23 from document 1:United States Pharmacopoeia, United States PharmacopoeiaConvention, Inc.; Rockville, MD, 2005; P.470.); Under its condition, because the strong chelating effect of primary hydroxyl group and ionizable metal salt, there is serious conditions of streaking at the material peak of Ciclopirox Olamine.In order to reduce chelating effect, before experiment, first water: acetonitrile: glacial acetic acid: (500: 500: 1: mixing eluent 1), the flushing chromatographic column is 15h at least, washes 5h at least with moving phase again for diacetone.But, even passed through flushing so for a long time, the detection Ciclopirox Olamine that this method still can not be successful.
Summary of the invention
On the basis of above-mentioned previous work, the object of the present invention is to provide a kind of method of measuring Ciclopirox Olamine.This method is utilized the clathration of beta-schardinger dextrin-, beta-schardinger dextrin-is added in the moving phase of high performance liquid chromatography, makes itself and Ciclopirox Olamine form special inclusion compound, reduces its suction-operated on chromatographic column, utilizes UV-detector to detect Ciclopirox Olamine.
The objective of the invention is to realize through following technical scheme:
A kind of method of measuring Ciclopirox Olamine the steps include:
A. the preparation of Ciclopirox Olamine standard solution
Prepare Ciclopirox Olamine standard items stock solution with acetonitrile as solvent: pipette the stock solution of certain volume,, then above-mentioned standard solution is placed irradiation under the uviol lamp, make standard solution with the solution of dilution in acetonitrile to some parts of variable concentrations;
B. The pretreatment
Accurately take by weighing an amount of Ciclopirox Olamine emulsifiable paste, place the 10mL volumetric flask, add absolute ethyl alcohol 7mL; Use the absolute ethyl alcohol constant volume behind the ultrasonic 20min, continue ultrasonic 5min, with the organic filtering with microporous membrane of 0.45 μ m; Pipetting 1.0mL filtrates in the 10mL volumetric flask; Shake up with the acetonitrile constant volume, then above-mentioned standard solution is placed irradiation under the uviol lamp, sample introduction is preceding with 0.45 μ m organic membrane filter;
C. the mensuration of liquid chromatography
Adopting the chromatographic column of C18 hydrophilic filler, is that water mixes as moving phase with the organic phase acetonitrile with the certain beta-schardinger dextrin-WS of pH, and flow rate of mobile phase is 1mL/min, and column temperature is 30~50 ℃, and the ultraviolet detection wavelength is 298 ± 5nm; Sample size is 20 μ L; Difference sample introduction standard solution and sample solution; Adopt peak area to concentration drawing curve; Obtaining equation of linear regression is: y=ax+b, and utilize sample solution peak area A to combine above-mentioned working curve to calculate the content of Ciclopirox Olamine in the Ciclopirox Olamine Ointment in Treatment, computing formula is following:
Sample solution concentration:
(1) in the formula: A is the sample solution peak area; A, b are respectively that equation of linear regression is: slope among the y=ax+b and intercept;
The percentage composition of Ciclopirox Olamine in the Ciclopirox Olamine Ointment in Treatment:
(2) c is a sample solution concentration in the formula; M is a Ciclopirox Olamine emulsifiable paste quality;
Advantage of the present invention: this is invented as a kind of mensuration Ciclopirox Olamine method; Beta-schardinger dextrin-is added in the moving phase; Utilize the clathration of beta-schardinger dextrin-to Ciclopirox Olamine; Having overcome Ciclopirox Olamine strong adsorption on chromatographic column can not be caused the shortcoming that it can't quantitative measurement by wash-out, thereby finds a kind of method of effective mensuration Ciclopirox Olamine.This invention has detectability low (detectability can reach 0.01ppm); The range of linearity is wide by (0.31~75.00ppm); The recovery is 95.9%; RSD=4.38%, its range of linearity has well covered the medication concentration range (4~8 μ g/ml) of Ciclopirox Olamine, therefore can well be used for the fast detecting and the clinical application monitoring of medicine production process Ciclopirox Olamine.
Description of drawings
Fig. 1 is a beta-cyclodextrin inclusion compound Ciclopirox Olamine structural representation.
Fig. 2 is the pure article standard of a Ciclopirox Olamine chromatogram.
Fig. 3 is the Ciclopirox Olamine standard working curve.
Fig. 4 is a Ciclopirox Olamine emulsifiable paste actual sample chromatogram, and 1 is the peak of sample 1, and 2 is the peak of sample 2.
The practical implementation method
The present invention adopts the Varian high performance liquid chromatography (to comprise ProStar 210 pumps; The 7725i sampling valve is 20 μ L injection annulus; UV-detector is ProStar325, and the chromatographic data analytic system is StarWS) and AE.LICHROM C18 5 μ m 150 * 4.6mm chromatographic column;
A kind of method of measuring Ciclopirox Olamine, its implementation process are divided into following four steps:
A. the preparation of Ciclopirox Olamine standard solution
Get 5.0mg Ciclopirox Olamine standard items, in the 5mL volumetric flask, make the stock solution of 1mg/mL with the acetonitrile constant volume; Pipetting volume respectively is the stock solution of 1.55 μ L, 3.15 μ L, 6.25 μ L, 12.50 μ L, 25.00 μ L, 50.00 μ L, 100.00 μ L, 250.005 μ L, 375.00 μ L, is respectively the solution of 0.31ppm, 0.63ppm, 1.25ppm, 2.50ppm, 5.00ppm, 10.00ppm, 20.00ppm, 50.00ppm, 75.00ppm with dilution in acetonitrile to concentration.Then above-mentioned standard solution is placed under the uviol lamp and shone 24 hours, make standard solution.
B. The pretreatment
Accurately take by weighing Ciclopirox Olamine emulsifiable paste 0.10g, 0.20g (production of field pharmaceutcal corporation, Ltd of Hubei section), be labeled as sample 1, sample 2 respectively; Place the 10mL volumetric flask then respectively, add absolute ethyl alcohol 7mL, use the absolute ethyl alcohol constant volume behind the ultrasonic 20min; Continue ultrasonic 5min; With the organic filtering with microporous membrane of 0.45 μ m, pipette 1.0mL and filtrate in 10mL volumetric flask for use, with the acetonitrile constant volume and shake up; Then above-mentioned constant volume solution is placed under the uviol lamp irradiation 24 hours, before the sample introduction with solution with 0.45 μ m organic membrane filter.
C. the drafting of working curve
The drafting of working curve of the present invention; Adopt the chromatographic column of C18 hydrophilic filler, with the beta-schardinger dextrin-WS of the 13.2mmol/L of pH=4.0: acetonitrile=50: 50 (V/V) is a moving phase, and flow rate of mobile phase is 1mL/min; Column temperature is 40 ℃, and the ultraviolet detection wavelength is 298nm; The finite concentration standard Ciclopirox Olamine standard solution 20 μ L that prepare in the sample introduction a step successively; Beta-schardinger dextrin-and Ciclopirox Olamine form inclusion compound; By the moving phase wash-out, adopt peak area to concentration drawing curve then, equation of linear regression is: y=9.6519x+2.3721; The range of linearity is 0.31~75.00ppm, linearly dependent coefficient R
2=0.9994, working curve is seen Fig. 3.
D. the mensuration of sample
Get the Ciclopirox Olamine emulsifiable paste sample feeding that 20 μ L handle well, under above-mentioned c step condition, measure.According to formula (1), formula (2), combine above-mentioned working curve to calculate the percentage composition of Ciclopirox Olamine in the Ciclopirox Olamine Ointment in Treatment with peak area.
Figure can know by Fig. 4 sample chromatogram, and the ratio of sample peak 1 and the area at sample peak 2 equals the mass ratio of sample 1 and sample 2 in the b step in the spectrogram, and visible in the range of linearity of 0.31~75.00ppm, the quantitative measurement of Ciclopirox Olamine is accurately; And then the Mass Calculation that combines sample 1 and sample 2 goes out that the percentage composition of Ciclopirox Olamine is 1% in the Ciclopirox Olamine Ointment in Treatment, is consistent with the product description of this ointment.
Claims (1)
1. a method of measuring Ciclopirox Olamine the steps include:
A. the preparation of Ciclopirox Olamine standard solution
Prepare Ciclopirox Olamine standard items stock solution with acetonitrile as solvent: pipette the stock solution of certain volume, with the solution of dilution in acetonitrile to some parts of variable concentrations, the solution with variable concentrations places irradiation under the uviol lamp then, makes standard solution;
B. The pretreatment
Accurately take by weighing an amount of Ciclopirox Olamine emulsifiable paste, place the 10mL volumetric flask, add absolute ethyl alcohol 7mL; Use the absolute ethyl alcohol constant volume behind the ultrasonic 20min, continue ultrasonic 5min, with the organic filtering with microporous membrane of 0.45 μ m; Pipetting 1.0mL filtrates in the 10mL volumetric flask; Shake up with the acetonitrile constant volume, then above-mentioned constant volume solution is placed irradiation under the uviol lamp, sample introduction is preceding with 0.45 μ m organic membrane filter;
C. the mensuration of liquid chromatography
Adopt the chromatographic column of C18 hydrophilic filler, with the beta-schardinger dextrin-WS of the 13.2mmol/L of pH=4.0: acetonitrile=50: 50V/V is a moving phase, and flow rate of mobile phase is 1mL/min, and column temperature is 40 ℃, and the ultraviolet detection wavelength is 298nm; Sample size is 20 μ L; Difference sample introduction standard solution and constant volume solution; Adopt peak area to concentration drawing curve; Obtaining equation of linear regression is: y=ax+b, and utilize sample solution peak area A to combine above-mentioned working curve to calculate the percentage composition of Ciclopirox Olamine in the Ciclopirox Olamine Ointment in Treatment, computing formula is following:
Sample solution concentration:
(1) in the formula: A is the sample solution peak area; A, b are respectively that equation of linear regression is: slope among the y=ax+b and intercept; The sample solution concentration unit is ppm;
The percentage composition of Ciclopirox Olamine in the Ciclopirox Olamine Ointment in Treatment:
(2) c is a sample solution concentration in the formula; M is a Ciclopirox Olamine emulsifiable paste quality.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910117707XA CN101750457B (en) | 2009-12-04 | 2009-12-04 | Method for measuring ciclopirox olamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910117707XA CN101750457B (en) | 2009-12-04 | 2009-12-04 | Method for measuring ciclopirox olamine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101750457A CN101750457A (en) | 2010-06-23 |
CN101750457B true CN101750457B (en) | 2012-05-23 |
Family
ID=42477751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910117707XA Expired - Fee Related CN101750457B (en) | 2009-12-04 | 2009-12-04 | Method for measuring ciclopirox olamine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101750457B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102313687A (en) * | 2011-07-29 | 2012-01-11 | 岳中瑾 | Method for detecting cream preparation for treating phimosis |
CN113075148B (en) * | 2021-03-22 | 2023-06-16 | 久泰能源(准格尔)有限公司 | Method for measuring carbon content of catalyst surface in MTO process |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085002A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | Compound red sage root freezing-dried powder injection containing borneol and its preparation method |
-
2009
- 2009-12-04 CN CN200910117707XA patent/CN101750457B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085002A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | Compound red sage root freezing-dried powder injection containing borneol and its preparation method |
Non-Patent Citations (3)
Title |
---|
Ana Laura V. Escarrone等.LC–UV Method with Pre-Column Derivatization for the Determination of Ciclopirox Olamine in Raw Material and Topical Solution.《Chromatographia》.2008,第67卷(第11/12期),967-971. * |
宋红萍等.环吡酮胺涂膜剂的制备及含量测定.《中国药师》.2007,第10卷(第6期),563-564. * |
王钟辉等.HP-β-CD对苯基琥珀酸对映体色谱保留机制及拆分机理的研究.《分析测试学报》.2009,第28卷(第2期),162-167. * |
Also Published As
Publication number | Publication date |
---|---|
CN101750457A (en) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103713056B (en) | Method for simultaneously analyzing and detecting residual veterinary drug compositions in animal tissue | |
Jayaprakasha et al. | Determination of organic acids in leaves and rinds of Garcinia indica (Desr.) by LC | |
Ferrone et al. | Air assisted dispersive liquid-liquid microextraction with solidification of the floating organic droplets (AA-DLLME-SFO) and UHPLC-PDA method: Application to antibiotics analysis in human plasma of hospital acquired pneumonia patients | |
CN103713077B (en) | The method of alpha-aminobutyric acid content in high effective liquid chromatography for measuring red colouring agent for food, also used as a Chinese medicine | |
Siewert | Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies | |
Havlíková et al. | HPLC determination of chlorhexidine gluconate and p-chloroaniline in topical ointment | |
CN103926340B (en) | The assay method of Nitrofuran antibiotics in a kind of cosmetics | |
Cox et al. | High-performance liquid chromatography determination of meloxicam and piroxicam with ultraviolet detection | |
Aminu et al. | Concurrent determination of triclosan and flurbiprofen by high-performance liquid chromatography in simulated saliva and its application in dental nanogel formulation | |
CN101750457B (en) | Method for measuring ciclopirox olamine | |
CN101929985A (en) | Method for measuring atorvastatin calcium associated matters by high performance liquid chromatography | |
Abdollahpour et al. | High performance liquid chromatographic determination of sodium benzoate, methylparaben and propylparaben as preservative components in nystatin suspensions | |
Şanli et al. | Optimization of the experimental conditions for macrolide antibiotics in high performance liquid chromatography by using response surface methodology and determination of tylosin in milk samples | |
Wu et al. | Liquid chromatographic method with amperometric detection to determine acteoside in rat blood and brain microdialysates and its application to pharmacokinetic study | |
CN112336693A (en) | Method for rapidly controlling and evaluating release of macitentan tablets | |
Wardrop et al. | Determination of erythromycin and related substances in enteric‐coated tablet formulations by reversed‐phase liquid chromatography | |
Salman | RP-HPLC Estimation of ceftriaxone sodium in pharmaceuticals | |
Hermawan et al. | Analysis of fluconazole in human urine sample by high performance liquid chromatography method | |
Sun et al. | Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography–tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy | |
CN102491926B (en) | Method for preparing and purifying tiopronin disulphide | |
Russo et al. | High-performance liquid chromatographic assay for thiopental in human plasma: Application to pharmacokinetic studies | |
Kim | Development of an ion-pairing reagent and HPLC-UV method for the detection and quantification of six water-soluble vitamins in animal feed | |
CN108152432B (en) | High performance liquid detection method for lotafloxacin tablets | |
Hosseini et al. | Nano Analysis in Biochemistry: In Vitro Separation and Determination of Aluminium in Blood of Dialysis Patients Based on Graphene Oxide Nanoparticles Dispersed to Ionic Liquid | |
Phapale et al. | Analysis of pazufloxacin mesilate in human plasma and urine by LC with fluorescence and UV detection, and its application to pharmacokinetic study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20141204 |
|
EXPY | Termination of patent right or utility model |